Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (241-250 of 385) with videos related to

Pageof 39
Sort By:
Cancer Research|April 21, 2011
Common and overlapping oncogenic pathways contribute to the evolution of acute myeloid leukemiasBrynn T Kvinlaug, Wai-In Chan, Lars Bullinger, et al.
Leukemia|October 3, 2023
Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patientsEkaterina Jahn, Maral Saadati, Pierre Fenaux, et al.
Blood Cancer Journal|September 16, 2024
Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapySophia Gross, Jana Ihlow, Leonie Busack, et al.
Blood|November 28, 2022
Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic strokeChristopher M Arends, Thomas G Liman, Paulina M Strzelecka, et al.
Leukemia|August 17, 2023
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patientsEkaterina Jahn, Maral Saadati, Pierre Fenaux, et al.
Cell|June 4, 2009
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cellsClaudia Scholl, Stefan Fröhling, Ian F Dunn, et al.
Blood|February 14, 2019
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrationsJonas Samuel Jutzi, Titiksha Basu, Maximilian Pellmann, et al.
Blood|May 25, 2013
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemiaJan Krönke, Lars Bullinger, Veronica Teleanu, et al.
Haematologica|October 15, 2020
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1Eugen Tausch, Philipp Beck, Richard F Schlenk, et al.
Blood|October 11, 2012
High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterationsJennifer Edelmann, Karlheinz Holzmann, Florian Miller, et al.
Pageof 39

Showing results (241-250 of 385) with videos related to

Sort By:
Pageof 39
Cancer Research|April 21, 2011
Common and overlapping oncogenic pathways contribute to the evolution of acute myeloid leukemiasBrynn T Kvinlaug, Wai-In Chan, Lars Bullinger, et al.
Leukemia|October 3, 2023
Correction: Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patientsEkaterina Jahn, Maral Saadati, Pierre Fenaux, et al.
Blood Cancer Journal|September 16, 2024
Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapySophia Gross, Jana Ihlow, Leonie Busack, et al.
Blood|November 28, 2022
Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic strokeChristopher M Arends, Thomas G Liman, Paulina M Strzelecka, et al.
Leukemia|August 17, 2023
Clinical impact of the genomic landscape and leukemogenic trajectories in non-intensively treated elderly acute myeloid leukemia patientsEkaterina Jahn, Maral Saadati, Pierre Fenaux, et al.
Cell|June 4, 2009
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cellsClaudia Scholl, Stefan Fröhling, Ian F Dunn, et al.
Blood|February 14, 2019
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrationsJonas Samuel Jutzi, Titiksha Basu, Maximilian Pellmann, et al.
Blood|May 25, 2013
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemiaJan Krönke, Lars Bullinger, Veronica Teleanu, et al.
Haematologica|October 15, 2020
Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1Eugen Tausch, Philipp Beck, Richard F Schlenk, et al.
Blood|October 11, 2012
High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterationsJennifer Edelmann, Karlheinz Holzmann, Florian Miller, et al.
Pageof 39